DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes. (Q51764065)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 October 2011
edit
Language Label Description Also known as
English
DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
scientific article published on 20 October 2011

    Statements

    DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit